Cannabinoids [electronic resource] / edited by Roger G. Pertwee.

Return to search

Call Number	615
Title	Cannabinoids edited by Roger G. Pertwee. with contributions by numerous experts
Physical Description	XII, 772 p. 87 illus., 3 illus. in color. online resource.
Series	Handbook of Experimental Pharmacology, 0171-2004 ; 168
Contents	Pharmacological Actions of Cannabinoids -- Cannabinoid Receptor Signaling -- Molecular Biology of Cannabinoid Receptors -- Analysis of the Endocannabinoid System by Using CB1 Cannabinoid Receptor Knockout Mice -- The Biosynthesis, Fate and Pharmacological Properties of Endocannabinoids -- Modulators of Endocannabinoid Enzymic Hydrolysis and Membrane Transport -- Structural Requirements for Cannabinoid Receptor Probes -- Cannabinoid Receptors and Their Ligands: Ligand—Ligand and Ligand—Receptor Modeling Approaches -- The Phylogenetic Distribution and Evolutionary Origins of Endocannabinoid Signalling -- Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System -- Effects of Cannabinoids on Neurotransmission -- Retrograde Signalling by Endocannabinoids -- Effects on the Immune System -- Imaging of the Brain Cannabinoid System -- Cannabinoid Function in Learning, Memory and Plasticity -- Cannabinoid Control of Motor Function at the Basal Ganglia -- Cannabinoid Mechanisms of Pain Suppression -- Effects of Cannabinoids on Hypothalamic and Reproductive Function -- Cannabinoids and the Digestive Tract -- Cardiovascular Pharmacology of Cannabinoids -- Effects on Cell Viability -- Effects on Development -- Pharmacokinetics and Metabolism of the Plant Cannabinoids, ?9-Tetrahydrocannibinol, Cannabidiol and Cannabinol -- Cannabinoid Tolerance and Dependence -- Human Studies of Cannabinoids and Medicinal Cannabis.
Summary	Less than 20 years ago the ?eld of cannabis and the cannabinoids was still c- sidered a minor, somewhat quaint, area of research. A few groups were active in the ?eld, but it was already being viewed as stagnating. The chemistry of cannabis 9 9 was well known, ? -tetrahydrocannabinol (? -THC), identi?ed in 1964, being the only major psychoactive constituent and cannabidiol, which is not psychoactive, possibly contributing to some of the effects. These cannabinoids and several s- thetic analogs had been thoroughly investigated for their pharmacological effects. Their mode of action was considered to be non-speci?c. The reasons for this - sumption were both technical and conceptual. On the technical side, it had been shown that THC was active in both enantiomeric forms (though with a different level of potency) and this observation was incompatible with action on biological substrates—a receptor, an enzyme, an ion channel—which react with a single stereoisomer only. The conceptual problem related to THC activity. This had been pointed out by several highly regarded research groups that had shown that many of the effects seen with cannabinoids were related to those of biologically active lipophiles, and that many of the effects of THC, particularly chronic ones, were comparable to those seen with anaesthetics and solvents.
Added Author	Pertwee, Roger G. editor. SpringerLink (Online service)
Subject	MEDICINE. NEUROSCIENCES. PHARMACOLOGY. MEDICINAL CHEMISTRY. Biomedicine. Pharmacology/Toxicology. Neurosciences. Medicinal Chemistry.
Multimedia	http://dx.doi.org/10.1007/b137831

Libraries with this item

950	Biomedical and Life Sciences (Springer-11642)

Total Ratings: 0

Copies
MARC Record
Reviews
Details


No records found to display.

04487nam a22005175i 4500

001

vtls001568646

003

VRT

005

20170831184200.0

007

cr nn 008mamaa

008

170831s2005 gw | s |||| 0|eng d

020

$a 9783540265733 $9 978-3-540-26573-3

024

$a 10.1007/b137831 $2 doi

035

$a (DE-He213)978-3-540-26573-3

039

$y 201708311842 $z santha

050

$a RM1-950

072

$a MMG $2 bicssc

072

$a MED071000 $2 bisacsh

082

$a 615 $2 23

245

$a Cannabinoids $h [electronic resource] / $c edited by Roger G. Pertwee.

246

$a with contributions by numerous experts

264

$a Berlin, Heidelberg : $b Springer Berlin Heidelberg, $c 2005.

300

$a XII, 772 p. 87 illus., 3 illus. in color. $b online resource.

336

$a text $b txt $2 rdacontent

337

$a computer $b c $2 rdamedia

338

$a online resource $b cr $2 rdacarrier

347

$a text file $b PDF $2 rda

490

$a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 168

505

$a Pharmacological Actions of Cannabinoids -- Cannabinoid Receptor Signaling -- Molecular Biology of Cannabinoid Receptors -- Analysis of the Endocannabinoid System by Using CB1 Cannabinoid Receptor Knockout Mice -- The Biosynthesis, Fate and Pharmacological Properties of Endocannabinoids -- Modulators of Endocannabinoid Enzymic Hydrolysis and Membrane Transport -- Structural Requirements for Cannabinoid Receptor Probes -- Cannabinoid Receptors and Their Ligands: Ligand—Ligand and Ligand—Receptor Modeling Approaches -- The Phylogenetic Distribution and Evolutionary Origins of Endocannabinoid Signalling -- Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System -- Effects of Cannabinoids on Neurotransmission -- Retrograde Signalling by Endocannabinoids -- Effects on the Immune System -- Imaging of the Brain Cannabinoid System -- Cannabinoid Function in Learning, Memory and Plasticity -- Cannabinoid Control of Motor Function at the Basal Ganglia -- Cannabinoid Mechanisms of Pain Suppression -- Effects of Cannabinoids on Hypothalamic and Reproductive Function -- Cannabinoids and the Digestive Tract -- Cardiovascular Pharmacology of Cannabinoids -- Effects on Cell Viability -- Effects on Development -- Pharmacokinetics and Metabolism of the Plant Cannabinoids, ?9-Tetrahydrocannibinol, Cannabidiol and Cannabinol -- Cannabinoid Tolerance and Dependence -- Human Studies of Cannabinoids and Medicinal Cannabis.

520

$a Less than 20 years ago the ?eld of cannabis and the cannabinoids was still c- sidered a minor, somewhat quaint, area of research. A few groups were active in the ?eld, but it was already being viewed as stagnating. The chemistry of cannabis 9 9 was well known, ? -tetrahydrocannabinol (? -THC), identi?ed in 1964, being the only major psychoactive constituent and cannabidiol, which is not psychoactive, possibly contributing to some of the effects. These cannabinoids and several s- thetic analogs had been thoroughly investigated for their pharmacological effects. Their mode of action was considered to be non-speci?c. The reasons for this - sumption were both technical and conceptual. On the technical side, it had been shown that THC was active in both enantiomeric forms (though with a different level of potency) and this observation was incompatible with action on biological substrates—a receptor, an enzyme, an ion channel—which react with a single stereoisomer only. The conceptual problem related to THC activity. This had been pointed out by several highly regarded research groups that had shown that many of the effects seen with cannabinoids were related to those of biologically active lipophiles, and that many of the effects of THC, particularly chronic ones, were comparable to those seen with anaesthetics and solvents.

650

$a MEDICINE.

650

$a NEUROSCIENCES.

650

$a PHARMACOLOGY.

650

$a MEDICINAL CHEMISTRY.

650

$a Biomedicine.

650

$a Pharmacology/Toxicology.

650

$a Neurosciences.

650

$a Medicinal Chemistry.

700

$a Pertwee, Roger G. $e editor.

710

$a SpringerLink (Online service)

773

$t Springer eBooks

776

$i Printed edition: $z 9783540225652

830

$a Handbook of Experimental Pharmacology, $x 0171-2004 ; $v 168

856

$u http://dx.doi.org/10.1007/b137831

912

$a ZDB-2-SBL

950

$a Biomedical and Life Sciences (Springer-11642)

999

$a VIRTUA

No Reviews to Display

Summary	Less than 20 years ago the ?eld of cannabis and the cannabinoids was still c- sidered a minor, somewhat quaint, area of research. A few groups were active in the ?eld, but it was already being viewed as stagnating. The chemistry of cannabis 9 9 was well known, ? -tetrahydrocannabinol (? -THC), identi?ed in 1964, being the only major psychoactive constituent and cannabidiol, which is not psychoactive, possibly contributing to some of the effects. These cannabinoids and several s- thetic analogs had been thoroughly investigated for their pharmacological effects. Their mode of action was considered to be non-speci?c. The reasons for this - sumption were both technical and conceptual. On the technical side, it had been shown that THC was active in both enantiomeric forms (though with a different level of potency) and this observation was incompatible with action on biological substrates—a receptor, an enzyme, an ion channel—which react with a single stereoisomer only. The conceptual problem related to THC activity. This had been pointed out by several highly regarded research groups that had shown that many of the effects seen with cannabinoids were related to those of biologically active lipophiles, and that many of the effects of THC, particularly chronic ones, were comparable to those seen with anaesthetics and solvents.
Contents	Pharmacological Actions of Cannabinoids -- Cannabinoid Receptor Signaling -- Molecular Biology of Cannabinoid Receptors -- Analysis of the Endocannabinoid System by Using CB1 Cannabinoid Receptor Knockout Mice -- The Biosynthesis, Fate and Pharmacological Properties of Endocannabinoids -- Modulators of Endocannabinoid Enzymic Hydrolysis and Membrane Transport -- Structural Requirements for Cannabinoid Receptor Probes -- Cannabinoid Receptors and Their Ligands: Ligand—Ligand and Ligand—Receptor Modeling Approaches -- The Phylogenetic Distribution and Evolutionary Origins of Endocannabinoid Signalling -- Distribution of Cannabinoid Receptors in the Central and Peripheral Nervous System -- Effects of Cannabinoids on Neurotransmission -- Retrograde Signalling by Endocannabinoids -- Effects on the Immune System -- Imaging of the Brain Cannabinoid System -- Cannabinoid Function in Learning, Memory and Plasticity -- Cannabinoid Control of Motor Function at the Basal Ganglia -- Cannabinoid Mechanisms of Pain Suppression -- Effects of Cannabinoids on Hypothalamic and Reproductive Function -- Cannabinoids and the Digestive Tract -- Cardiovascular Pharmacology of Cannabinoids -- Effects on Cell Viability -- Effects on Development -- Pharmacokinetics and Metabolism of the Plant Cannabinoids, ?9-Tetrahydrocannibinol, Cannabidiol and Cannabinol -- Cannabinoid Tolerance and Dependence -- Human Studies of Cannabinoids and Medicinal Cannabis.
Subject	MEDICINE. NEUROSCIENCES. PHARMACOLOGY. MEDICINAL CHEMISTRY. Biomedicine. Pharmacology/Toxicology. Neurosciences. Medicinal Chemistry.
Multimedia	http://dx.doi.org/10.1007/b137831